Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 475 of 506 entries
View as:

Clinical Outcomes for Offering Genetic Testing in a Tiered Approach

Phase: N/A Priority: Normal
NCT ID: NCT04902144 Org: User:
Start: 08/03/20 End: 12/31/21 Due: 12/31/22

Financial Navigation Program Intervention in Supporting Patients With Solid Tumors and Their Caregivers

Phase: N/A Priority: Normal
NCT ID: NCT03775616 Org: User:
Start: 11/15/17 End: 05/15/19 Due: 05/15/20

A Multilevel Intervention to Increase Colorectal Cancer Screening Tests in Patients With Abnormal Fecal Immunochemical Test Results, PROACT Trial

Phase: N/A Priority: Normal
NCT ID: NCT06822530 Org: User:
Start: 09/01/25 End: 11/30/29 Due: 11/30/30

Malaria Clinical Trials Center General Screening

Phase: N/A Priority: Normal
NCT ID: NCT02119312 Org: User:
Start: 06/30/10 End: 09/01/20 Due: 09/01/21

Melphalan With or Without Holmium Ho 166 DOTMP Followed by Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT00008229 Org: User:
Start: 08/31/00 End: 09/30/01 Due: 09/30/02

Radiolabeled Monoclonal Antibody and Combination Chemotherapy Before Stem Cell Transplant in Treating Patients With High-Risk Lymphoid Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT01921387 Org: User:
Start: 10/09/13 End: 07/26/20 Due: 07/26/21

A Study to Establish a New Onset Hyperglycemia and Diabetes Cohort

Phase: N/A Priority: Normal
NCT ID: NCT03731637 Org: User:
Start: 10/15/18 End: 03/31/25 Due: 03/31/26

Comparing ATG or Post-Transplant Cyclophosphamide to Calcineurin Inhibitor-Methotrexate as GVHD Prophylaxis After Myeloablative Unrelated Donor Peripheral Blood Stem Cell Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT03602898 Org: User:
Start: 06/01/21 End: 09/17/23 Due: 09/17/24

Combination Chemotherapy and Antithymocyte Globulin in Reducing Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplantation For Myelodysplastic Syndrome or Myeloproliferative Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00054340 Org: User:
Start: 10/31/02 End: 09/30/06 Due: 09/30/07

Study of Metabolic Syndrome in Adolescent and Young Adult Survivors of Childhood Leukemia Who Have Undergone Stem Cell Transplant

Phase: N/A Priority: Normal
NCT ID: NCT00920842 Org: User:
Start: 04/30/05 End: 11/30/12 Due: 11/30/13

Improving Outcomes Assessment in Chronic GVHD

Phase: N/A Priority: Normal
NCT ID: NCT00637689 Org: User:
Start: 09/30/07 End: 02/28/27 Due: 02/28/28

Ice Chips or Saline Mouth Rinse in Reducing or Preventing Mucositis in Patients Receiving Melphalan and Autologous Stem Cell Transplant for Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT00118339 Org: User:
Start: 07/31/03 End: 05/31/06 Due: 05/31/07

IVIG for Infection Prevention After CAR-T-Cell Therapy

Phase: N/A Priority: Normal
NCT ID: NCT05952804 Org: User:
Start: 06/10/24 End: 07/31/28 Due: 07/31/29

An AHEI Dietary Intervention to Reduce Pain in Women With Endometriosis

Phase: N/A Priority: Normal
NCT ID: NCT04259788 Org: User:
Start: 05/24/21 End: 02/28/26 Due: 02/28/27

Rituximab in Treating Patients Undergoing Donor Peripheral Blood Stem Cell Transplant for Relapsed or Refractory B-cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00867529 Org: User:
Start: 02/28/09 End: 03/26/15 Due: 03/26/16

Long-Term Oral Acyclovir Usage to Prevent Herpes Zoster Virus Infection After Bone Marrow Transplant

Phase: N/A Priority: Normal
NCT ID: NCT00209352 Org: User:
Start: 06/30/85 End: 07/31/04 Due: 07/31/05

Infusion of Expanded Cord Blood Cells in Addition to Single Cord Blood Transplant in Treating Patients With Acute Leukemia, Chronic Myeloid Leukemia, or Myelodysplastic Syndromes

Phase: N/A Priority: Normal
NCT ID: NCT03399773 Org: User:
Start: 05/10/22 End: 09/30/27 Due: 09/30/28

Belumosudil for the Pre-emptive Treatment of Patients With Chronic Graft Versus Host Disease

Phase: N/A Priority: Normal
NCT ID: NCT05996627 Org: User:
Start: 12/06/23 End: 12/31/27 Due: 12/31/28

DR-18 for the Treatment of Relapsed or Persistent Acute Myeloid Leukemia or Myelodysplastic Syndrome After Hematopoietic Cell Transplantation, the DR. DREAM Trial

Phase: N/A Priority: Normal
NCT ID: NCT06492707 Org: User:
Start: 09/23/24 End: 10/01/27 Due: 10/01/28

Effect of Exercise on Biomarkers of Colon Cancer Risk

Phase: N/A Priority: Normal
NCT ID: NCT00668161 Org: User:
Start: 01/31/01 End: 02/28/05 Due: 02/28/06

Blood Samples to Identify Biomarkers of Busulfan

Phase: N/A Priority: Normal
NCT ID: NCT02291965 Org: User:
Start: 11/30/14 End: 10/07/24 Due: 10/07/25

Sustained Oral Fiber Supplementation for Patients Undergoing Donor Stem Cell Transplantation for Hematological Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT04829136 Org: User:
Start: 06/22/22 End: 12/31/27 Due: 12/31/28

Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation, and Donor Bone Marrow Transplant Followed by Donor Natural Killer Cell Therapy, Mycophenolate Mofetil, and Tacrolimus in Treating Patients With Hematologic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00789776 Org: User:
Start: 10/13/08 End: 05/31/17 Due: 05/31/18

Gene-Modified Immune Cells (FH-MCVA2TCR) in Treating Patients With Metastatic or Unresectable Merkel Cell Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03747484 Org: User:
Start: 07/03/19 End: 01/09/24 Due: 01/09/25

Fiber and Fish Oil Supplements for the Prevention of Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04211766 Org: User:
Start: 01/05/21 End: 08/16/22 Due: 08/16/23